Abstract:Background: A large number of breast cancer patients perishes due to metastasis instead of primary tumor, but molecular mechanisms contributing towards cancer metastasis remain poorly understood. Therefore, prompting development of novel treatment is inevitable. A vast variety of plant derived natural substance possesses several therapeutically active constituents, e.g. alkaloids, flavonoids, tannins, resins, terpenoids etc. that exhibit various pharmacological properties e.g. anti-inflammatory, anti-microbial and anti-cancer properties. Sanguinarine (SAN) alkaloid found its place among such naturally occurring substances that exerts several pharmacological activities, including anti-cancer effects.Purpose: Until now, role of SAN not only against epithelial-mesenchymal transition (EMT) but also against metastasis progression in breast cancer remains indistinct. Thus, aim of the present study was to investigate effects of SAN on EMT process and cancer metastasis in animal model.Methods: MTT assay was performed to assess SAN effects on proliferation in breast cancer. Scratch assay was performed to evaluate effects of SAN on migration in breast cancer. Colony formation assay was performed to determine effects of SAN on colonization characteristics of breast cancer. Western blotting was performed to measure EMT regulating protein expression as well as major pathway protein expression induced against TGF-β treatment in breast cancer. Tail vein method of injecting breast cancer cells in bulb/c mice was conducted to study metastasis progression and thereafter assessing effects of SAN against metastasis in mice.Results: In vitro results: MTT assay performed, demonstrated dose dependent inhibition of cell proliferation in breast cancer. Scratch assay results showed, SAN played a major role as migration inhibitor in estrogen receptor positive (ER+) breast cancer. Colony forming assay results demonstrated that SAN constrains ability of breast cancer to develop into well-defined colonies. Western blotting results for EMT regulating protein expression, after TGF-β treatment showed, SAN inhibited cadherin switch in ER+ breast cancer. Moreover, expression of pathway proteins involved in EMT process after TGF-β treatment i.e. Smad, PI3K/Akt and MAP kinase were significantly masked against SAN treatment.In vivo results: The appearance of metastatic nodules in lung tissues of mice model, helps to study the effects of SAN against metastasis in bulb/c mice. The obtained results have confirmed that SAN impeded lung metastasis. The macroscopic examination has confirmed metastasis inhibitory role of SAN in breast cancer. The Hematoxylin and eosin (H&E) staining results further advocate anti-metastatic characteristics of SAN, presented by fewer metastatic nodule and lesions appearance in SAN treated mice compared to untreated metastasis mice.Conclusion: In summary, SAN displayed prominent anti-metastatic effects in animal model and anti-proliferation effects together with significant inhibitory potential on EMT regulating protein expression against TGF-β treatment in ER+ breast cancer. So, overall findings of our study highlighted the pre-clinical significance of SAN in animal model therefore, further studies in humans as a part of clinical trial will be needed to establish pharmacokinetics and other effects of SAN, so that it can be a potential candidate for future treatment of metastatic breast cancer (MBC).

Rational Optimizations of the Marine-Derived Peptide Sungsanpin As Novel Inhibitors of Cell Invasion.

Further structural optimization and SAR study of sungsanpin derivatives as cell-invasion inhibitors

Peniciketal A, A Novel Spiroketal Compound, Exerts Anticancer Effects by Inhibiting Cell Proliferation, Migration and Invasion of A549 Lung Cancer Cells.

Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.

CS5931, A Novel Marine Polypeptide, Inhibits Migration and Invasion of Cancer Cells Via Interacting with Enolase 1.

Design, SAR, Angiogenic Activities Evaluation and Pro-Angiogenic Mechanism of New Marine Cyclopeptide Analogs.

Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.

Antineoplastic Effects and Mechanisms of a New RGD Chimeric Peptide from Bullfrog Skin on the Proliferation and Apoptosis of B16F10 Cells

A Frog-Derived Bionic Peptide With Discriminative Inhibition Of Tumors Based On Integrin Alpha V Beta 3 Identification

Synthesis and Anticancer Activity of Novel Actinonin Derivatives As HsPDF Inhibitors

Novel Production Method of Innovative Antiangiogenic and Antitumor Small Peptides in Escherichia Coli

Design, Synthesis And Structure-Activity Relationship Studies Of Novel Survivin Inhibitors With Potent Anti-Proliferative Properties

Chemically Synthesized Matrix Metalloproteinase and Angiogenesis-Inhibiting Peptides As Anticancer Agents.

Inhibition of Angiogenesis by a Novel Small Peptide Consisting of the Active Fragments of Platelet Factor-4 and Vasostatin

Design, Synthesis and Sar Studies of Tripeptide Analogs with the Scaffold 3-Phenylpropane-1,2-diamine As Aminopeptidase N/Cd13 Inhibitors

A Diterpenoid Compound, Excisanin A, Inhibits The Invasive Behavior Of Breast Cancer Cells By Modulating The Integrin Beta 1/Fak/Pi3k/Akt/Beta-Catenin Signaling

Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor

Design, Synthesis and Biological Evaluation of Tanshinone IIA-based Analogues: Potent Inhibitors of Microtubule Formation and Angiogenesis

Peptidomimetics and Metalloprotease Inhibitors As Anticancer Drugs

Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer

Experiment Study on the Role of RGD-Modified Endostatin Peptide 30 Derived from Endostatin in the Invasion and Migration Process of SGC-7901 Cells